Your browser doesn't support javascript.
loading
Effectiveness and safety of lenvatinib plus anti-programmed death-1 antibodies in patients with hepatocellular carcinoma: A real-world cohort study.
Xu, Ming-Hao; Huang, Cheng; Li, Mei-Ling; Zhu, Xiao-Dong; Tan, Chang-Jun; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan; Shen, Ying-Hao.
Afiliación
  • Xu MH; Department of Liver Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Huang C; Department of Liver Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Li ML; Department of Liver Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhu XD; Department of Liver Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Tan CJ; Department of Liver Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhou J; Department of Liver Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Fan J; Department of Liver Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Sun HC; Department of Liver Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Shen YH; Department of Liver Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Cancer Med ; 12(8): 9202-9212, 2023 04.
Article en En | MEDLINE | ID: mdl-36790032
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos